As new hardware and software are introduced into interventional suites, imaging labs and surgical theaters, who bears responsibility for bringing medical personnel up to speed on the advantages they could deliver for safety and efficacy?

Geisinger is aiming to offer DNA sequencing to all of its 1.5 million patients. Members of its precision health team reveal how the initiative developed and share insights gleaned so far, challenges ahead and questions still to be answered.

A new stem cell-based test may add certainty to efforts to predict whether so-called variants of uncertain significance will contribute to the development of diseases or be harmless. 

Coronary artery calcium scanning is not a Magic 8 Ball, but it is a powerful predictor and a valuable tool for cardiology practices.

Cardiologists want solid proof of AI’s efficacy and value. And even then, obstacles to acceptance may remain.

Even though the Hospital Readmission Reduction Program (HRRP) targeted principal heart failure admissions, a new analysis in the Journal of the American College of Cardiology showed readmissions also declined for patients with a secondary diagnosis of heart failure.

MIT researchers have developed a near-infrared imaging technique that can detect tumors deep in internal tissue before the cancer grows beyond a few hundred cells.

The FDA on March 7 granted Breakthrough Device designation to Paige.AI, a year-old New York startup that’s using AI to help diagnose and treat cancer, the company announced.

Researchers looked at data from more than 2,500 free-text radiology reports of patients undergoing hepatocellular carcinoma surveillance to determine if an NLP approach could extract clinical data and predict downstream utilization of resources.

Researchers in Britain are calling for better, faster tests to distinguish between viral and bacterial illness in children presenting to emergency rooms with a fever. Such a development would save children and their families the anxiety of unnecessary exams, including imaging, and make a meaningful dent in the financial burden on the U.K’s National Health Service.